Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to 2q24 microdeletion

Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to 2q24 microdeletion is an extremely rare chromosomal disorder caused by a contiguous gene deletion on the long arm of chromosome 2, in the 2q24 region. This microdeletion encompasses several genes, and the resulting syndrome is characterized by a combination of neurodevelopmental and movement disorder features. The condition falls under the broader category of partial monosomies of the long arm of chromosome 2 (classified under ICD-10 code Q93.5, indicating other deletions of part of a chromosome). Key clinical features include global developmental delay, significant language and speech impairment, dystonia that is responsive to levodopa (dopa-responsive dystonia), and parkinsonism. The neurological manifestations reflect disruption of dopaminergic pathways, which is consistent with the deletion of genes in the 2q24 region known to be involved in neurotransmitter metabolism or neuronal function. Affected individuals may present in childhood with motor difficulties, abnormal posturing, and progressive movement abnormalities alongside cognitive and language delays. Treatment is primarily symptomatic and supportive. The dopa-responsive dystonia component is particularly important to recognize, as affected individuals may show significant improvement in dystonic and parkinsonian symptoms with levodopa therapy. Speech therapy, physical therapy, occupational therapy, and educational support are important components of multidisciplinary management. Genetic counseling is recommended for affected families. Due to the extreme rarity of this condition, management is largely guided by case reports and expert opinion rather than large clinical trials.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to 2q24 microdeletion